Skip to main content

Table 2 Univariate and multivariate analysis and predictors of NOAF variable univariate analysis multivariate analysis

From: The association between systemic inflammatory response index and new-onset atrial fibrillation in patients with ST-elevated myocardial infarction treated with percutaneous coronary intervention

 

OR

95% CI

P value

OR

95% CI

P value

SIRI

1.160

1.103–1.221

< 0.001

1.782

1.675–1.906

0.001

Age, years

1.072

1.041–1.103

< 0.001

   

Male

0.546

0.282–1.056

0.072

   

BMI, kg/m2

1.171

0.999–1.373

0.052

   

Killip class ≥ 2

4.782

2.591–8.826

< 0.001

   

Hypertension

1.686

0.916–3.106

0.093

   

Diabetes mellitus

2.421

1.275–4.594

0.007

   

Smoking

0.699

0.384–1.272

0.241

   

Alcohol consumption

1.264

0.673–2.373

0.466

   

Cardiogenic shock

3.833

1.966–7.473

< 0.001

   

Biochemical indicators

White blood cells, 109/L

1.165

1.085–1.251

< 0.001

   

Hemoglobin (g/l)

0.977

0.959–0.995

0.011

   

Lymphocyte (109/l)

0.190

0.094–0.382

< 0.001

   

Neutrophil (109/l)

1.120

1.048–1.197

0.001

   

Monocyte (109/l)

11.453

4.650-28.209

< 0.001

   

Platelet, 109/L

0.997

0.992–1.003

0.308

   

NLR

1.125

1.080–1.171

< 0.001

   

MLR

10.320

4.705–22.635

< 0.001

   

Albumin, g/L

0.818

0.749–0.892

< 0.001

0.820

0.715–0.940

0.004

Glucose, mmol/L

1.146

1.070–1.228

< 0.001

1.129

1.022–1.246

0.017

Total cholesterol, mmol/L

0.768

0.586–1.006

0.056

   

Triglyceride, mmol/L

1.018

0.795–1.304

0.885

   

HDL-c, mmol/L

4.492

1.574–12.815

0.005

   

LDL-c, mmol/L

0.554

0.360–0.851

0.007

   

eGFR, (ml/min*1.73m2)

0.988

0.979–0.996

0.005

0.985

0.972–0.997

0.015

Peak CK (*103U/L)

1.000

1.000–1.000

0.149

   

Coronary angiography

Culprit vessel LADa

0.778

0.422–1.433

0.421

   

Culprit vessel LCXa

0.419

0.095–1.846

0.250

   

TIMI 3 flow pre-PCI

1.769

0.733–4.267

0.204

   

Stent-length

1.022

1.004–1.040

0.018

   

SYNTAX score

1.055

1.012-1.100

0.012

   

Residual SYNTAX score

1.054

1.005–1.105

0.03

   

LA

1.132

1.063–1.206

< 0.001

   

LVEF

0.938

0.902–0.975

0.001

   

Medication during hospitalization

 ACEI/ARB

1.150

0.630–2.099

0.648

   

 Beta-blockers

0.403

0.219–0.741

0.003

   

 MRA

3.368

1.801–6.298

< 0.001

   

 Statin

0.881

0.334–2.320

0.797

   
  1. NOAF, New-onset atrial fibrillation; SIRI, System inflammation response index; BMI, Body mass index; NLR, Neutrophil/lymphocyte ratio; MLR, Monocyte/lymphocyte ratio; HDL-c, High-density lipoprotein cholesterol; LDL-c, Low-density lipoprotein cholesterol; eGFR, Estimated glomerular filtration rate; CK, Creatine kinase; LAD, Left anterior descending coronary artery; LCX, Left circumflex coronary artery; RCA, Right coronary artery; TIMI, Thrombolysis in myocardial infarction; SYNTAX, SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery; LA, Left atrium; LVEF, Left ventricular ejection fraction; ACEI, Angiotensin-converting enzyme inhibitor; ARB, Angiotensin receptor blocker; MRA, Mineralocorticoid receptor antagonist; PCI, Percutaneous coronary intervention
  2. aCompared with culprit vessel RCA